# Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing

> **NCT02998112** · PHASE4 · UNKNOWN · sponsor: **The Second Hospital of Nanjing Medical University** · enrollment: 188 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** fecal microbiota transplantation
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02998112
- **Lead sponsor:** The Second Hospital of Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2017-07
- **Final completion:** 2017-12
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2016-12-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02998112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02998112, "Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02998112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
